3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish
JournalPharmacological Research
Volume156
DOIs
StatePublished - 1 Jun 2020

Cite this